FIELD: medicine; pharmacology.
SUBSTANCE: crystal epirubicine hydrochloride of type II has diffraction pattern of X-ray powder scattering providing average diffraction angles (2θ) and relative intensities P(%), presented in the Table indicated below:
EFFECT: effective application of new crystal form for cancer treatment in people and animals.
6 cl, 7 dwg, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE CRYSTALLINE MONOHYDRATE OF HYDROCHLORIDE EPIRUBICIN AND METHOD FOR ITS PRODUCTION | 2014 |
|
RU2630692C2 |
| STABLE CRYSTALLINE MONOHYDRATE OF EPIRUBICIN HYDROCHLORIDE AND METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2700683C2 |
| 2-[4-(METHYLAMINOMETHYL)PHENYL]-5-FLUORO-BENZOFURAN-7-CARBOXAMIDE HYDROCHLORIDE POLYMORPHOUS, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2783418C1 |
| CRYSTALLINE FORMS OF TIGECYCLINE AND METHOD FOR PREPARING THEM | 2006 |
|
RU2478612C2 |
| STABLE CRYSTALLINE FORM OF 2-ETHYL-3,7-DIMETHYL-6-(4-TRIFLUOROMETHOXY)PHENOXY)QUINOLIN-4-YLMETHYLCARBONATE, METHOD OF OBTAINING THEREOF AND AGROCHEMICAL COMPOSITION, CONTAINING SAID CRYSTALLINE FORM | 2011 |
|
RU2545094C2 |
| CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[b]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE | 2011 |
|
RU2577334C2 |
| COMMERCIAL METHOD FOR PREPARING OFFICINAL DIOSMIN AND CRYSTALLINE FORM THEREOF (VERSIONS) | 2011 |
|
RU2481353C1 |
| STABLE CRYSTALLINE FORM OF TYPIRACYL HYDROCHLORIDE AND METHOD FOR ITS CRYSTALLIZATION | 2014 |
|
RU2640417C2 |
| ACID ADDITION SALT OF TRK INHIBITING COMPOUND | 2015 |
|
RU2708236C2 |
| NOVEL POLYMORPHIC FORMS OF ICOTINIB PHOSPHATE AND USES THEREOF | 2014 |
|
RU2712169C2 |
